AlphaYou
Overview
Smart money at a glance
Filings to Oct 1, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: both buying and selling, $2K to $30K in total in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- $2K to $30K tradedMixed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 5 added, 2 cutMore adding
Key stats
Fundamentals Sep 30- Open
- $161.35
- 52-wk high
- $233.40
- High
- $162.62
- 52-wk low
- $133.01
- Low
- $159.93
- Prev close
- $162.92
- Mkt cap
- $18.17B
- P/E
- 17.0x
- Volume
- 908.0K
- Fwd P/E
- 15.5x
- Beta
- 0.91
- Div yield
- 2.39%
- P/S
- 2.4x
- P/B
- 6.6x
- Profit margin
- +15.0%
- Op margin
- +24.6%
- ROE
- +40.9%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about BR filings
Are insiders buying or selling Broadridge Financial Solutions Inc (BR) stock?
Neither. Broadridge Financial Solutions Inc (BR) insiders filed no open-market purchases or sales in the 90 days to Oct 1, 2026, according to SEC Form 4 filings.
Which members of Congress have traded BR recently?
Rep. Gilbert Cisneros (D) bought $1K to $15K on Jun 16, 2026, disclosed 16 days later. Rep. Rick Larsen (D) sold $1K to $15K on Apr 7, 2026, disclosed 8 days later. In total, 2 members disclosed 2 BR trades with trade dates in the last 180 days, filed a median 12 days after trading.
How current is this BR smart-money data?
This summary uses filings available on Oct 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (3)
- TS
Two Sigma
$145.8M
added
- QR
Qube Research
$95.2M
added
- CI
Citadel
$86.5M
added
What insiders are doing
Sells (1)
- JH
Jarkowski Hope M.
$305K
sold
What Congress is doing
Sells (1)
How top traders are positioned
No tracked top-trader positions in BR right now.
Live Hyperliquid positioning - not every stock is covered
Activist stakes, short interest & more
Earnings
Earnings came in 1.9% above what analysts expected.
Earnings per share
$3.75 expected
Reports Nov 3, 2026, in 33 days
Estimates as of Sep 30, 2026
EPS expected
$1.29 to $1.47
Revenue expected
7 analysts
Last 30 days
Analysts cutting estimates
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.59B | $1.71B | $1.95B | $2.22B |
| Cost of what it sold | $1.17B | $1.24B | $1.33B | $1.37B |
| Gross profit | $422.6M | $473.6M | $626.9M | $852.9M |
| What it spent | ||||
| Sales and admin | $233.9M | $267.5M | $267.4M | $306.7M |
| Total operating expenses | $233.9M | $265.2M | $267.4M | $309.0M |
| What was left | ||||
| Operating profit | $188.8M | $208.4M | $359.5M | $546.2M |
| Interest on debt | $27.9M | $27.7M | $27.3M | $26.9M |
| Profit before tax | $213.1M | $370.2M | $340.6M | $521.9M |
| Tax | $47.7M | $85.7M | $64.3M | $123.9M |
| Net profit | $165.4M | $284.6M | $276.3M | $398.0M |
| EBITDA | $363.4M | $525.1M | $465.8M | $546.2M |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage leans bullish
Broadridge and Korea Securities Depository Sign MOU to Support Modernization of Proxy Voting for International Investors Holding Korean Equities
BullishSep 28Here's Why You Should Retain Broadridge Stock in Your Portfolio
NeutralSep 28Director Eileen K. Murray reports 6,147 Broadridge (BR) shares after a deferred-pay stock award.
NeutralSep 28Broadridge (NYSE: BR) director receives 209 stock units in place of deferred cash pay
NeutralSep 28Cash pay became stock units for Broadridge (NYSE: BR) director Annette L. Nazareth.
NeutralSep 28Medtronic plc Business Combination Communication | MDT SEC Filing - Form 425
NeutralSep 26Advisor moves: Raymond James lands $1.25B team as Merrill loses two
NeutralSep 25Canopy Growth Announces Adjournment of 2026 Annual General and Special Meeting Due to Lack of Quorum
NeutralSep 25